IndiaOne Finance - Company Dashboard

Governance Classic Home

Sun Pharma Advanced Research Company LtdPharmaceuticalsINE232I01014Consolidated₹193.92+0.76 (+0.39%)Jun-26

Valuation

Market Cap₹6.29K Cr

TTM PE3.97x

Forward PE2.84x

PEG1.98

Book Value₹41.26

P/B4.70x

TTM EPS₹48.81

Fwd EPS₹68.20

TTM Revenue₹1.91K Cr

TTM PAT₹1.58K Cr

TTM EBITDA₹1.62K Cr

TTM EBIT₹1.61K Cr

Last Qtr PAT₹-20.78 Cr

Last Qtr EBITDA₹-34.00 Cr

Last Qtr EBIT₹-36.20 Cr

Profitability

ROE118.33%

ROCE93.58%

TTM NPM82.97%

TTM EBITDA %84.68%

Curr OPM-32.68%

Last OPM94.95%

Curr NPM—

Last NPM—

Curr EPS₹-0.64

Last EPS₹54.27

Balance sheet

Equity₹32.45 Cr

Reserve₹1.31K Cr

Total Debt₹559.31 Cr

D/E0.42x

Interest %-39.12%

Curr Interest₹8.13 Cr

Price / range

Close₹193.92

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+0.39%

1W-1.07%

1M+0.51%

3M-20.02%

6M+61.33%

1Y+34.81%

2Y-12.03%

3Y-17.36%

5Y-33.28%

Diwali+43.64%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	39.92+314.1%	1,853.22	8.45	7.86	9.64	1,879.17
Other Income	23.66	1.80	0	0.01	9.02	10.83
Total Income	63.58+240.7%	1,855.02	8.45	7.87	18.66	1,890
Interest	8.13	11.64	8.78	7.52	6.18	34.12
Expenditure	-84.56-19.6%	-94.32	-76.66	-83.84	-70.69	-325.51
PBDT	0	0	0	0	0	0
EBITDA	-34.31+34.4%	1,772.94	-56.87	-65.89	-52.33	1,597.85
Depreciation	-2.20	-2.40	-2.56	-2.57	-2.54	-10.07
EBIT	-36.51+33.5%	1,770.54	-59.43	-68.46	-54.87	1,587.78
PBT	-20.98+59.7%	1,760.70	-80.57	-75.97	-52.03	1,552.13
Tax	0	0	0	0	0	0
Equity	32.45	32.45	32.45	0	32.45	32.45
OPM	-33.00	94.92	-953.49	-966.54	-278.83	82.12
Net Profit	-20.98+59.7%	1,760.70	-80.57	-75.97	-52.03	1,552.13
NPM	-33.00	94.92	-953.49	-966.54	-278.83	82.12
EPS	-0.65+59.4%	54.26	-2.48	-2.34	-1.60	47.83

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,879.17+2518.3%	71.77-5.0%	75.55-68.4%	238.78+74.0%	137.25-45.7%	252.96
Other Income	10.83	1.79	29.47	10.88	6.84	5.41
Total Income	1,890+2469.3%	73.56-30.0%	105.02-57.9%	249.66+73.3%	144.09-44.2%	258.37
Expenditure	-325.51+22.3%	-418.78+15.1%	-493.13-4.4%	-472.24-35.9%	-347.49+15.1%	-409.51
Interest	-34.12	-8.91	-1.66	-7.63	-13.33	-10.65
PBDT	0	0	0	0	0	0
EBITDA	1,597.85+588.2%	-327.27+19.0%	-403.79-88.6%	-214.06-14.6%	-186.75-38.4%	-134.98
Depreciation	-10.07	-10.83	-12.13	-11.77	-10.16	-10.92
EBIT	1,587.78+569.6%	-338.10+18.7%	-415.92-84.2%	-225.83-14.7%	-196.91-35.0%	-145.90
PBT	1,552.13+549.6%	-345.22+11.1%	-388.11-74.4%	-222.58-9.4%	-203.40-34.6%	-151.14
Tax	0	0	0	0	0	0
Equity	32.45	32.45	0	0	0	0
OPM (%)	82.12	-469.30	-370.00	-89.00	-141.00	-58.00
Net Profit	1,552.13+549.6%	-345.22+11.1%	-388.11-74.4%	-222.58-9.4%	-203.40-34.6%	-151.14
NPM (%)	82.12	-469.30	-370.00	-89.00	-141.00	-58.00
EPS (Rs)	47.83	0+100.0%	-11.96-52.9%	-7.82-1.2%	-7.73-34.0%	-5.77
CEPS	47.83	0	-11.96	-7.82	7.73	-5.77

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	39.92+314.1%	1,853.22	8.45	7.86	9.64	1,879.17
Other Income	23.66	1.80	0	0.01	9.14	10.95
Total Income	63.58+238.6%	1,855.02	8.45	7.87	18.78	1,890.12
Interest	8.13	11.64	8.78	7.52	6.19	34.13
Expenditure	-84.25-19.4%	-94.06	-76.44	-83.66	-70.59	-324.75
PBDT	0	0	0	0	0	0
EBITDA	-34+34.7%	1,773.20	-56.64	-65.72	-52.08	1,598.76
Depreciation	-2.20	-2.40	-2.57	-2.56	-2.68	-10.21
EBIT	-36.20+33.9%	1,770.80	-59.21	-68.28	-54.76	1,588.55
PBT	-20.67+60.1%	1,760.96	0	0	-51.81	1,553.01
Tax	-0.11	0.38	-0.07	-0.06	-0.06	0.19
Equity	32.45	32.45	0	0	32.45	32.45
OPM	-32.51	94.93	0.00	0.00	-275.88	82.16
Net Profit	-20.78+59.9%	1,761.34	-80.42	-75.85	-51.87	1,553.20
NPM	-32.68	94.95	-951.72	-963.79	-276.20	82.17
EPS	-0.64+60.0%	54.27	-2.48	-2.34	-1.60	47.86

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24
Revenue	1,879.17+2518.3%	71.77-5.0%	75.55
Other Income	10.95	1.79	29.47
Total Income	1,890.12+2469.5%	73.56-30.0%	105.02
Expenditure	-324.75+22.0%	-416.34+15.4%	-491.85
Interest	-34.13	-9.04	-1.69
PBDT	0	0	0
EBITDA	1,598.76+594.8%	-323.14+19.6%	-402.10
Depreciation	-10.21	-12.39	-12.51
EBIT	1,588.55+573.4%	-335.53+19.1%	-414.61
PBT	1,553.01+553.1%	-342.78+11.4%	-386.83
Tax	0.19	0.27	-0.38
Equity	32.45	32.45	0
OPM (%)	82.16	-465.99	-368.34
Net Profit	1,553.20+553.5%	-342.51+11.5%	-387.21
NPM (%)	82.17	-465.62	-368.70
EPS (Rs)	47.86	0+100.0%	-11.93
CEPS	0	0	-11.93

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split